Potential role of estrogen receptor α (ERα) phosphorylated at Serine118 in human breast cancer in vivo

Journal of Steroid Biochemistry and Molecular Biology

Volumn 102, Issue 1-5 SPEC. ISS., 2006, Pages 139-146

  Murphy, Leigh C ^a   Weitsman, G E ^a   Skliris, G P ^a   Teh, E M ^a   Li, Lin ^a   Peng, B ^a   Davie, J R ^a   Ung, K ^a   Niu, Y L ^a   Troup, S ^a   Tomes, L ^a   Watson, P H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Estrogen action; Estrogen receptor; Growth factor receptors; Kinases; Phosphorylation

Indexed keywords

BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHORYLATION; SERINE;

EID: 33751002354     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.09.021     Document Type: Article

References (63)

1. Osborne C., and Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J. Clin. Oncol. 23 (2005) 1616-1622
2. Lannigan D. Estrogen receptor phosphorylation. Steroids 68 1 (2003) 1-9
3. Tremblay A., Tremblay G., Labrie F., and Giguere V. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol. Cell 3 4 (1999) 513-519
4. Lahooti H., White R., Hoare S., Rahman D., Pappin D., and Parker M. Identification of phosphorylation sites in the mouse oestrogen receptor. J. Steroid Biochem. Mol. Biol. 55 (1995) 305-313
5. Joel P., Traish A., and Lannigan D. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J. Biol. Chem. 273 21 (1998) 13317-13323
6. Chen D., Washbrook E., Sarwar N., Bates G., Pace P., Thirunuvakkarasu V., Taylor J., Epstein R., Fuller-Pace F., Egly J., et al. Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 21 32 (2002) 4921-4931
7. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., et al. Activation of the estrogen receptor through phosphorylation by mitogen activated protein kinase. Science 270 (1995) 1491-1494
8. Bunone G., Briand P.-A., Miksicek R., and Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phorphorylation. EMBO J. 15 9 (1996) 2174-2183
9. Migliaccio A., Domenico M.D., Castoria G., Falco A.D., Bontempo P., Nola E., and Aurrichio F. Tyrosine kinase/p21ras/MAP kinase pathway activation by estradiol receptor complex in MCF-7 cells. EMBO J. 15 6 (1996) 1292-1300
10. Park K., Krishnan V., O'Malley B., Yamamoto Y., and Gaynor R. Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol. Cell 18 1 (2005) 71-82
11. Medunjanin S., Hermani A., Servi B.D., Grisouard J., Rincke G., and Mayer D. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity. J. Biol. Chem. 280 (2005) 33006-33014
12. Martin L., Farmer I., Johnston S., Ali S., Marshall C., and Dowsett M. Enhanced ERalpha ERBB2 and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term oestrogen deprivation. J. Biol. Chem. 29 (2003) (epub ahead of print)
13. Coutts A., and Murphy L. Elevated mitogen activated protein kinase activity in estrogen non-responsive human breast cancer cells. Cancer Res. 58 (1998) 4071-4074
14. Jeng M., Yue W., Eischeid A., Wang J., and Santen R. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breastcancer cells. Breast Cancer Res. Treat. 62 (2000) 167-175
15. Dowsett M., Johnston S., Martin L., Salter J., Hills M., Detre S., Gutierrez M., Mohsin S.K., Shou J., Allred D., et al. Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience. Endocr. Relat. Cancer 12 Suppl 1 (2005) S113-S117
16. Osborne C., Shou J., Massarweh S., and Schiff R. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin. Cancer Res. 11 2 Pt 2 (2005) 865s-870s
17. Murphy L.C., Cherlet T., Adeyinka A., Niu Y., Snell L., and Watson P. Phospho-Serine-118 estrogen receptor-alpha detection in human breast tumors in vivo. Clin. Cancer Res. 10 (2004) 1354-1359
18. Murphy L., Niu Y., Snell L., and Watson P. Phospho-Serine-118 estrogen receptor-alpha expression in primary human breast tumors in vivo is associated with better disease outcome in women treated with tamoxifen. Clin. Cancer Res. 10 17 (2004) 5902-5906
19. Gee J., Robertson J., Gutteridge E., Ellis I., Pinder S., Rubini M., and Nicholson R. Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr. Relat. Cancer 12 Suppl. 1 (2005) S99-S111
20. Yamashita H., Nishio M., Kobayashi S., Ando Y., Sugiura H., Zhang Z., Hamaguchi M., Mita K., Fujii Y., and Iwase H. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer. Breast Cancer Res. 7 (2005) R753-R764
21. Weitsman G., Li L., Skliris G., Davie J., Ung K., Curtis-Snell L., Tomes L., Watson P., and Murphy L. Estrogen receptor-alpha phosphorylated at Serine 118 is present at the promoters of estrogen-regulated genes and is not altered due to Her2 over-expression. Cancer Res. (2006)
22. Berry M., Nunez A., and Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 1218-1222
23. Espino P., Li L., He S., Yu J., and Davie J. Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras/mitogen-activated protein kinase pathway. Cancer Res. 66 (2006) 4610-4616
24. Petz L., Ziegler Y., Loven M., and Nardulli A. Estrogen receptor a and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Endocrinology 143 (2002) 4583-4591
25. Petz L., Ziegler Y., Schultz J., Kim H., Kemper J., and Nardulli A. Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites. J. Steroid Biochem. Mol. Biol. 88 2 (2004) 113-122
26. Cicatiello L., Addeo R., Sasso A., Altucci L., Petrizzi V., Borgo R., Cancemi M., Caporali S., Caristi S., Scafoglio C., et al. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol. Cell. Biol. 24 (2004) 7260-7274
27. Dubik D., and Shiu R.P. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7 8 (1992) 1587-1594
28. Shou J., Massarweh S., Osborne C., Wakeling A., Ali S., Weiss H., and Schiff R. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J. Natl. Cancer Instit. 96 12 (2004) 926-935
29. Osborne C., Bardou V., Hopp T., Chamness G., Hilsenbeck S., Fuqua S., Wong J., Allred D., Clark G., and Schiff R. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J. Natl. Cancer Instit. 95 5 (2003) 353-361
30. Gburcik V., Bot N., Maggiolini M., and Picard D. SPBP is a phosphoserine-specific repressor of estrogen receptor alpha. Mol. Cell. Biol. 25 (2005) 3421-3430
31. Masuhiro Y., Mezaki Y., Sakari M., Takeyama K., Yoshida T., Inoue K., Yanagisawa J., Hanazawa S., O'malley B., and Kato S. Splicing potentiation by growth factor signals via estrogen receptor phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 102 23 (2005) 8126-8131
32. Endoh H., Maruyama K., Masuhiro Y., Kobayashi Y., Goto M., Tai H., Yanagisawa J., Metzger D., Hashimoto S., and Kato S. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol. Cell. Biol. 19 8 (1999) 5363-5372
33. Callige M., Kieffer I., and Richard-Foy H. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome. Mol. Cell. Biol. 25 11 (2005) 4349-4358
34. Valley C., Metivier R., Solodin N., Fowler A., Mashek M., Hill L., and Alarid E. Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus. Mol. Cell. Biol. 25 13 (2005) 5417-5428
35. Oesterreich S., Zhang P., Guler R., Sun X., Curran E., Welshons W., Osborne C., and Lee A. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res. 61 (2001) 5771-5777
36. Arnold S., Obourn J., Jaffe H., and Notides A. Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol. 8 (1994) 1208-1214
37. Clark D., Poteet-Smith C., Smith J., and Lannigan D. Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain. EMBO J. 20 (2001) 3484-3494
38. Joel P., Smith J., Sturgill T., Fisher T., Blenis J., and Lannigan D.A. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18 4 (1998) 1978-1984
39. Castana E., Vorojeikina D., and Notides A. Phosphorylation of serine-167 on the human oestrogen receptor is important for oestrogen response element binding and transcriptional activation. Biochem. J. 326 Pt 1 (1997) 149-157
40. Campbell R., Bhat-Nakshatri P., Patel N., Constantinidou D., Ali S., and Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 276 13 (2001) 9817-9824
41. Shah Y., and Rowan B. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity. Mol. Endocrinol. 19 (2005) 732-748
42. Arnold S., Obourn J., Jaffe H., and Notides A. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase. II. Consequence on DNA binding. J. Steroid Biochem. Mol. Biol. 55 (1995) 163-172
43. Sun M., Paciga J., Feldman R., Yuan Z., Coppola D., Lu Y., Shelley S., Nicosia S., and Cheng J. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res. 61 16 (2001) 5985-5991
44. Tokunaga E., Kataoka A., Kimura Y., Oki E., Mashino K., Nishida K., Koga T., Morita M., Kakeji Y., Baba H., et al. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur. J. Cancer 42 (2006) 629-635
45. F.M. Al-Dhaheri, B. Rowan, Application of phosphorylation site-specific antibodies to measure nuclear receptor signalling: characterization of novel phosphoantibodies for estrogen receptor alpha, Nucl. Recept. Signal (2006) 4:e007 (Epub April 28).
46. Polychronis A., Sinnett H.D., Hadjiminas D., Singhal H., Mansi J., Shivapatham D., Shousha S., Jiang J., Peston D., Barrett N., et al. Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial. Lancet Oncol. 6 (2005) 383-391
47. Kim M.Y., Woo E.M., Chong Y.T., Homenko D.R., and Kraus W.L. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol. Endocrinol. 20 7 (2006) 1479-1493 Epub 2006 Feb 23
48. Sen C., and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10 (1996) 709-720
49. Sentis S., Romancer M.L., Bianchin C., Rostan M., and Corbo L. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol. Endocrinol. 19 (2005) 2671-2684
50. Wijayaratne A., and McDonnell D. The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J. Biol. Chem. 276 38 (2001) 35684-35692
51. Carder P., Murphy C., Dervan P., Kennedy M., McCann A., Saunders P., Shaaban A., Foster C., Witton C., Bartlett J., et al. A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue. Breast Cancer Res. Treat. 92 3 (2005) 287-293
52. Watson P., Snell L., and Parisien M. The NCIC-Manitoba breast tumor bank: a resource for applied cancer research. CMAJ 155 (1996) 281-283
53. Snell L., and Watson P. Breast tissue banking: collection, handling, storage, and release of tissue for breast cancer research. Meth. Mol. Med. 120 (2006) 3-24
54. Rogatsky I., Trowbridge J., and Garabedian M. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. J. Biol. Chem. 274 (1999) 22296-22302
55. Dutertre M., and Smith C. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol. Endocrinol. 17 (2003) 1296-1314
56. Chen D., Washbrook E., Sarwar N., Pace P., Coombes R., Egly J., and Ali S. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell. Biol. 6 (2000) 127-137
57. Chen D., Pace P., Coombes R., and Ali S. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol. Cell. Biol. 19 (1999) 1002-1015
58. Michalides R., Griekspoor A., Balkenende A., Verwoerd D., Janssen L., Jalink K., Floore A., Velds A., van't Veer L., and Neefjes J. Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer. Cancer Cell 5 (2004) 597-605
59. Lee H., and Bai W. Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol. Cell. Biol. 22 (2002) 5835-5845
60. Arnold S., Obourn J., Jaffe H., and Notides A. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosines in vitro. Mol. Endocrinol. 9 (1995) 24-33
61. Arnold S., Vorojeikina D., and Notides A. Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J. Biol. Chem. 270 50 (1995) 30205-30212
62. Kim H., Laing M., and Muller W. c-Src-null mice exhibit defects in normal mammary gland development and ERalpha signaling. Oncogene 24 (2005) 5629-5636
63. Marquez D., Lee J., Lin T., and Pietras R. Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor. Endocr. Relat. Cancer 16 (2001) 73-81